Newark Venture Partners Crosses $200M AUM With Second Fund
Newark Venture Partners crossed $200M in AUM with a second fund to back vertical AI founders, supported by LPs including Rutgers, Prudential, and Audible.
Startup Funding Guides & Investor Research
Raising startup funding requires matching your stage, traction, and sector to the right investors. Our startup funding resources cover everything from first checks to growth rounds — with actionable guidance for founders navigating today's market.
Startup Funding Essentials
- Stage alignment: Seed, Series A, and growth investors have different risk and return profiles
- Investor targeting: Thesis fit, portfolio overlap, and check-size compatibility
- Fundraising process: Decks, data rooms, diligence, and term negotiation
- Market timing: When to raise, how much to raise, and runway planning
Explore startup funding articles to sharpen your raise and find investors who fit your company.
Related Articles (825 articles)
-
-
MetaProp Backs Maybern $50M Series B and LightTable Series A
MetaProp backed Maybern’s $50M Series B fund-management platform and LightTable’s Series A, continuing its built-world software thesis.
-
Asymmetric Capital Partners Closes $137M Fund II
Asymmetric Capital Partners closed Fund II at $137M, beating its $125M target and pushing total AUM past $240M for vertical software and healthcare IT.
-
Digital Currency Group Anchors Yuma Asset Management With $10M
Digital Currency Group anchored the launch of Yuma Asset Management with a $10M seed, offering structured exposure to Bittensor subnet tokens.
-
NYC VC Scene (Archive): Historical 2024 Data + Where to Find 2026 Rankings
Historical snapshot of NYC venture capital (Q4 2024 figures preserved). For current 2026 rankings, stage shortlists, and deal activity, use our canonical NYC guides linked below.
-
Zeal Capital Partners Leads Rising Team and Seven Starling Rounds
Zeal Capital Partners led an $8M Series A in Rising Team and backed Seven Starling’s $8M maternal-health round, deploying its new Fund II.